Eсozitrin is a combination of clarithromycin and lactulose.
Measuring of medicine: 250 mg tablets #14 and 500 mg tablets #14.
A series of clinical surveys shows safety superiority concerning negative influence on beneficial intestine microbial balance comparing to effectiveness of the original medicine.
Indications for prescription (see USPI).
Can be included to eradicative therapy especially during retreatment.
Eсozitrin is well tolerated by patients and promotes response of patients to treatment. It has dual immune stimulating effect.